Evidence map›Paper›PMID 35682549›Full record

ReviewInternational journal of molecular sciences2022

The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor.

Emad A Ahmed, Peramaiyan Rajendran, Harry Scherthan

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. miRVim: Three-dimensional miRNA Structure Database.MicroRNA (Shariqah, United Arab Emirates) · 2025
    Article
  10. Advances in MiRNAs Involved in Endometrial Carcinoma.Combinatorial chemistry & high throughput screening · 2025
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Interplay between LncRNAs and microRNAs in Breast Cancer.International journal of molecular sciences · 2023
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 4 countries.

Emad A AhmedBiological Sciences Department, College of Science, King Faisal University, Hofuf 31982, Saudi Arabia.ORCID 0000-0002-5289-2966
Peramaiyan RajendranBiological Sciences Department, College of Science, King Faisal University, Hofuf 31982, Saudi Arabia.ORCID 0000-0001-6354-4388
Harry ScherthanInstitut für Radiobiologie der Bundeswehr in Verb. mit der Universität Ulm, 80937 Munich, Germany.
King Faisal University · SAUniversität Ulm · DE

Funding

King Faisal University AN0006
6 · The paper itself

Abstract

MicroRNA-202 (miR-202) is a member of the highly conserved let-7 family that was discovered in

Indexed as

Gene Expression Regulation, NeoplasticMicroRNAsBiomarkersCarcinogenesisCell Line, TumorCell ProliferationForkhead Transcription FactorsHumansMaleMembrane ProteinsRNA-Binding ProteinsBiomarkersForkhead Transcription FactorsFOXR2 protein, humanMembrane ProteinsMicroRNAsMIRN202 microRNA, humanMTDH protein, humanRNA-Binding Proteinscancerdiagnostic biomarkerslncRNAmicroRNA-202tumor suppressor

Identifiers

PMID35682549
PMCPMC9180238
OpenAlexW4281565159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.